Drug Database
Back to search

Netherlands· NL-3184a88f7099

Revinty Ellipta 184 mcg/22 mcg inhalatiepoeder, voorverdeeld

A vilanterol und fluticason furoat product containing fluticasonfuroaat + vilanteroltrifenataat, registered in Netherlands by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R03AK10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedRevinty Ellipta 184 mcg/22 mcg inhala…ATCR03AK10REGISTER NO.NL-3184a88f7099PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluticasonfuroaat + vilanteroltrifenataatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Vilanterol und fluticason furoat is registered in 11 of 19 countries.

Countries holding a registration under ATC R03AK10 (vilanterol und fluticason furoat), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search vilanterol und fluticason furoat products by name

Vilanterol und fluticason furoat · ATC R03AK10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of vilanterol und fluticason furoat costs, country by country.

Normalised to the WHO defined daily dose (25 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Vilanterol und fluticason furoat · price per daily dose (25 mcg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.30
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLUTICASONFUROAAT + VILANTEROLTRIFENATAAT
Manufacturer
GlaxoSmithKline Trading Services Limited
Country
Netherlands (NL)
ATC code
R03AK10
ATC class
Vilanterol und Fluticason furoat
Defined daily dose
25 mcg, Inhal
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/14/929

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for vilanterol und fluticason furoat.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check vilanterol und fluticason furoat against other medicinesHow interaction checks work

Vilanterol und fluticason furoat · interactions on record

1 record

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same class

Other records under R03AK10

Vilanterol und fluticason furoat, as other registers publish it.

All vilanterol und fluticason furoat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f709f117-7efa-4a79-b2c1-a4d3dfe390e8
GET /v1/drugs/f709f117-7efa-4a79-b2c1-a4d3dfe390e8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Inhalatiepoeder, voorverdeeld",
  "route": "Inhalatie",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/revinty-ellipta-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Vilanterol and fluticasone furoate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp114914",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "FLUTICASONFUROAAT",
    "VILANTEROLTRIFENATAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/05/02",
  "procedure_number": "EMEA/H/C/002745",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/929",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about vilanterol und fluticason furoat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console